---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-009146"
form_type: "8-K"
ticker: "PMI"
cik: "0002030617"
company_name: "Picard Medical, Inc."
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:58:08.619317+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Picard Medical Q3 revenue up 35% to $1.19M; IPO nets $15.5M in September

## Summary
- Revenue $1.19M (+35% YoY); gross loss narrowed 81% to $0.13M; operating loss $3.36M vs $3.77M.
- Net loss $22.7M includes $12.4M non-cash derivative revaluation charge upon IPO debt conversion.
- IPO completed Sept 2: $19.5M gross proceeds ($15.5M net); retired convertible debt.
- Appointed independent directors Sam Van and George Ye; patent granted for next-gen Emperor artificial heart.
- Year-to-date revenue $3.93M (+11%); operating loss $10.3M; EPS ($0.96) vs ($1.79) prior.

## SEC filing metadata
- accession: 0001829126-25-009146
- form_type: 8-K
- ticker: PMI
- cik: 0002030617
- company_name: Picard Medical, Inc.
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030617/000182912625009146/0001829126-25-009146-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030617/000182912625009146/picardmedical_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-009146
- JSON: https://secwatch.observer/filing/0001829126-25-009146.json
- Plain text: https://secwatch.observer/filing/0001829126-25-009146.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.